PTC Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to PTC Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Corporate Update

PTC Therapeutics (PTCT) Misses Q3 EPS by 97c, Revenues Beat

October 29, 2020 5:14 PM EDT

PTC Therapeutics (NASDAQ: PTCT) reported Q3 EPS of ($1.03), $0.97 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $118.4 million versus the consensus estimate of $112.21 million.

"I am very pleased by the rapid progress that we have made this... More